Lateral flow tests have all the hallmarks of a quality diagnostic test.
Fast-acting and versatile, they can be used at the point of care with or without a reader, meaning that they’re easy to use, require little training and are easily deployed in any location.
This extraordinary technology is an area where Mologic are continuing to make huge advances.
Speaking with Paul Davis, Co-founder and Chief Scientific Officer at Mologic, it was fascinating to hear what he had to say on the next steps for lateral flow. How could we improve this beautifully simple technology?
In an ever-changing industry, how can cell and gene therapy start-ups remain dynamic to new challenges to not only survive coming changes but thrive? Click to read more.
Are you attracting the very best industry talent to your start-up? For expert advice on how to thrive in today’s life science talent market, watch CM Life Science's latest 30-minute webinar. Click to watch.